Approval · Notice of Compliance 5024 · 1995
RHINALAR: Notice of Compliance 5024
Issued April 19, 1995
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5024
- Date
- April 19, 1995
- Company
- Hoffmann-La Roche LimitedMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Corticosteroid
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| RHINALAR | 02162687 | Cancelled Post Market |
Medicinal ingredients
- FLUNISOLIDE 25 MCG per ACT